Sign in
Stories
Alleged Investor Misconduct Lawsuits Alert
Share
Alleged Misconduct Spurs Class Actions
Investor Alert: Legal Actions Impact Bio...
Investor Lawsuit Alarms in Pharma
AMYLYX PHARMACEUTICALS Lawsuit Deadline ...
AVXL Lawsuit Roils Investors
AVXL Lawsuit: Deceptive Practices Expose...
Overview
API
Investors in BioVie Inc., Amylyx Pharmaceuticals, and BioNTech SE have been notified by The Gross Law Firm of class action lawsuits due to alleged misconduct, misleading statements, and overstating of vaccine demand, respectively.
Ask a question
How can investors safeguard themselves against potential risks related to companies facing such legal challenges?
How might these lawsuits impact the reputation and future prospects of the respective pharmaceutical companies?
What measures could regulatory bodies implement to prevent similar cases of misleading statements in the pharmaceutical industry?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage